iCAD

Performance

About iCAD

iCAD is a global leader in clinically proven AI-powered breast health solutions, transforming cancer detection through ProFound AI to help radiologists and patients with early breast cancer detection, density assessment, and risk evaluation. Headquartered with operations around the world, the company provides a suite of breast health AI tools designed to improve diagnostic accuracy, reduce recalls, and streamline radiology workflows. iCAD emphasizes evidence-based imaging, regulatory clearances, and collaborations with partners to advance cancer detection. Their platform supports 2D/3D mammography and is marketed to providers, patients, and researchers worldwide.